Matches in SemOpenAlex for { <https://semopenalex.org/work/W3125994857> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W3125994857 endingPage "128" @default.
- W3125994857 startingPage "128" @default.
- W3125994857 abstract "128 Background:The BRAF V600E mutation is a marker of poor prognosis in patients with metastatic colorectal cancer (mCRC). Targeted therapy, such as encorafenib plus cetuximab, is approved in the US/Europe for the treatment (tx) of BRAF V600E-mutated mCRC and demonstrated improved survival vs historical standard of care (SOC). Determining BRAF mutation status in mCRC is recommended by NCCN and ESMO guidelines although adherence to guidelines may not be uniform. This report’s objective is to communicate global survey results of mCRC BRAF testing practices. Identifying regions where BRAF testing is not SOC may help identify where education efforts are needed improve effective tx decision making. Methods: Oncology tx centers were identified from a registry and public information. Centers were selected for research experience, historic data quality, and estimated mCRC patients. A BRAF testing practices survey using an online platform of verified centers was conducted March-August 2020; 395 centers/38 countries have responded thus far. Results: Respondents indicated BRAF-mutation testing is performed as SOC for patients with mCRC in most regions; Eastern Europe and South America are exceptions: only 47% (45/95) and 45% (9/20) of centers, respectively routinely performed mutation testing. Most test tumor tissue, few test both tumor tissue or blood, and none conduct blood mutation testing only. Most regions perform BRAF testing at initial diagnosis or confirmation of advanced disease. Individual country statistics will be presented. Conclusions: BRAF testing has global variability, impacting tx decisions. Increased awareness and routine testing may lead to informed decisions regarding targeted therapies, such as encorafenib plus cetuximab where approved, in patients with BRAF V600E-mutant mCRC. [Table: see text]" @default.
- W3125994857 created "2021-02-01" @default.
- W3125994857 creator A5006614349 @default.
- W3125994857 creator A5022372583 @default.
- W3125994857 creator A5029434394 @default.
- W3125994857 creator A5038339239 @default.
- W3125994857 creator A5041301470 @default.
- W3125994857 creator A5043177546 @default.
- W3125994857 creator A5052136953 @default.
- W3125994857 creator A5057458005 @default.
- W3125994857 creator A5062748030 @default.
- W3125994857 creator A5063738443 @default.
- W3125994857 creator A5069877747 @default.
- W3125994857 creator A5078038970 @default.
- W3125994857 creator A5088658336 @default.
- W3125994857 creator A5090645179 @default.
- W3125994857 date "2021-01-20" @default.
- W3125994857 modified "2023-10-16" @default.
- W3125994857 title "Global BRAF testing practices in metastatic colorectal cancer." @default.
- W3125994857 doi "https://doi.org/10.1200/jco.2021.39.3_suppl.128" @default.
- W3125994857 hasPublicationYear "2021" @default.
- W3125994857 type Work @default.
- W3125994857 sameAs 3125994857 @default.
- W3125994857 citedByCount "0" @default.
- W3125994857 crossrefType "journal-article" @default.
- W3125994857 hasAuthorship W3125994857A5006614349 @default.
- W3125994857 hasAuthorship W3125994857A5022372583 @default.
- W3125994857 hasAuthorship W3125994857A5029434394 @default.
- W3125994857 hasAuthorship W3125994857A5038339239 @default.
- W3125994857 hasAuthorship W3125994857A5041301470 @default.
- W3125994857 hasAuthorship W3125994857A5043177546 @default.
- W3125994857 hasAuthorship W3125994857A5052136953 @default.
- W3125994857 hasAuthorship W3125994857A5057458005 @default.
- W3125994857 hasAuthorship W3125994857A5062748030 @default.
- W3125994857 hasAuthorship W3125994857A5063738443 @default.
- W3125994857 hasAuthorship W3125994857A5069877747 @default.
- W3125994857 hasAuthorship W3125994857A5078038970 @default.
- W3125994857 hasAuthorship W3125994857A5088658336 @default.
- W3125994857 hasAuthorship W3125994857A5090645179 @default.
- W3125994857 hasConcept C121608353 @default.
- W3125994857 hasConcept C126322002 @default.
- W3125994857 hasConcept C143998085 @default.
- W3125994857 hasConcept C2778332735 @default.
- W3125994857 hasConcept C2779998722 @default.
- W3125994857 hasConcept C2781230642 @default.
- W3125994857 hasConcept C512399662 @default.
- W3125994857 hasConcept C526805850 @default.
- W3125994857 hasConcept C71924100 @default.
- W3125994857 hasConceptScore W3125994857C121608353 @default.
- W3125994857 hasConceptScore W3125994857C126322002 @default.
- W3125994857 hasConceptScore W3125994857C143998085 @default.
- W3125994857 hasConceptScore W3125994857C2778332735 @default.
- W3125994857 hasConceptScore W3125994857C2779998722 @default.
- W3125994857 hasConceptScore W3125994857C2781230642 @default.
- W3125994857 hasConceptScore W3125994857C512399662 @default.
- W3125994857 hasConceptScore W3125994857C526805850 @default.
- W3125994857 hasConceptScore W3125994857C71924100 @default.
- W3125994857 hasIssue "3_suppl" @default.
- W3125994857 hasLocation W31259948571 @default.
- W3125994857 hasOpenAccess W3125994857 @default.
- W3125994857 hasPrimaryLocation W31259948571 @default.
- W3125994857 hasRelatedWork W1997977112 @default.
- W3125994857 hasRelatedWork W2010163599 @default.
- W3125994857 hasRelatedWork W2066879544 @default.
- W3125994857 hasRelatedWork W2066973685 @default.
- W3125994857 hasRelatedWork W2580187200 @default.
- W3125994857 hasRelatedWork W2784706285 @default.
- W3125994857 hasRelatedWork W3030758306 @default.
- W3125994857 hasRelatedWork W3152235123 @default.
- W3125994857 hasRelatedWork W3180628252 @default.
- W3125994857 hasRelatedWork W76115934 @default.
- W3125994857 hasVolume "39" @default.
- W3125994857 isParatext "false" @default.
- W3125994857 isRetracted "false" @default.
- W3125994857 magId "3125994857" @default.
- W3125994857 workType "article" @default.